Advantage India
Skilled human
capital
*With a total population of 1.4 billion, 47% being under the age of 25, India has a large pool of young and skilled workforce.
*The country is globally recognised for its dynamic innovation ecosystem and expanding biotech start-up base (11,855 start-ups in 2025).
*Increasing focus on advanced domains such as cell and gene therapy and precision medicine is strengthening future-ready capabilities.
*India has 1,39,489 MBBS and 86,360 postgraduate medical seats in government and private medical colleges across the country during the academic year 2025-2026.
Infrastructure
facilities
*The government, at present, supports nine biotechnology parks in various states, with the bulk being in the southern region and 73 BIRAC-supported bio-incubators as of early 2026.
*Union Minister of Earth Sciences Dr. Jitendra Singh inaugurates the Northeast's first International Biotech Conclave.
*Government of Odisha launched a five-year “Development of Biotechnology” umbrella scheme (2025-26 to 2029-30) with an outlay of Rs. 1,113.50 crore (US$ 126 million) to position the state as a biotechnology hub, comprising 17 sub-schemes focused on infrastructure development, research advancement and start-up incubation.
*Department for Promotion of Industry and Internal Trade (DPIIT) signed an MoU with Thermo Fisher Scientific to support over 500 biotech startups in the next three years through advisory, technology access, mentorship, and investor connect.
Policy
Support
*Policy focus on advanced biomanufacturing, precision fermentation, next-generation therapeutics and diagnostics is accelerating India’s transition towards high-value biotech segments.
*The Research, Development and Innovation (RDI) Fund, valued at US$ 11.60 billion (Rs. 1 lakh crore), is supporting deep-tech innovation across sectors, including biotechnology.
*The Government has approved the Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India, with a total budgetary outlay of Rs. 6,940 crore (US$ 882.95 million) and scheme tenure from FY2022-23 to FY2028–29.
*NBM supports 101 projects, involving over 150 organisations and 30 MSMEs. It has also generated over 1,000 jobs, including 304 scientists and researchers. Additionally, the Genome India Programme, which involves sequencing 10,000 genomes, is expected to shape future global healthcare strategies, both in treatment and prevention.
Epidemiological
factors
*The country has undertaken large-scale preventive screening, with 41.5 crore individuals screened for hypertension, 41.3 crore for diabetes, 35.3 crore for oral cancer and 16.5 crore for breast cancer, reflecting strong focus on early diagnosis and disease management.
*Rising prevalence of lifestyle-related conditions is accelerating demand for vaccines, biologics, diagnostics and personalised medicine.
*The country is expected to have around 134 million people with diabetes by 2045, while non-communicable diseases (NCDs) currently account for approximately 63% of all deaths in the country.
Related News
MOREBIOTECHNOLOGY CLUSTERS
- Haryana
- Bengaluru
- West Bengal
- Maharashtra
Industry Contacts
- Department of Biotechnology, Ministry of Science & Technology
- Department of Science and Technology, Ministry of Science and Technology
- Biotechnology Industry Research Assistance Council (BIRAC)
- Council of Scientific and Industrial Research (CSIR)
- Association of Biotechnology Led Enterprises (ABLE)
- The Biotech Research Society, India
Posters
MORE
Biotech Companies in India
The Indian biotechnology sector is expected to clock US$ 10 billion in revenue by 2015 on the back of emerging opportunities from around the world.
IBEF Campaigns
MORE
Case Studies
MOREContainerisation: Transforming India's Maritime Trade
Despite other modes of transportation, the maritime shipping mode is the backbone of international trade. The concept of containerisation has revoluti...
India’s Growing Senior Care Needs: New Businesses and Services
The current state of India is characterised by the process of demographic transition with gradual growth of the proportion of senior citizens within t...
The Rise of India's Pathology Laboratories: Strengthening Quality and Safety in Healthcare
India has seen its healthcare system witness an impressive evolution in the last two decades because of the growth in healthcare infrastructure, incre...
IBEF BLOG
MORE
India's Blue Economy: Untapped Potential in Ports, Fisheries and Ocean Resources
The maritime space of India, which comprises the coastline, island areas, a...
How Technology Is Making Waste Management More Efficient in Indian Cities
Indian cities are adopting digital monitoring, sensors, and automated waste...
India's Cold Chain Logistics: The Backbone of Perishable Trade
India's cold chain network allows the transfer of perishables from farm...
Partners
